Nuwellis Inc (NUWE): Kapitalisasi marang pendapatan

Simbol lan logo merek Nuwellis Inc (NUWE)

Risks are associated with basic emission controls and the processing of defective products. The revenue valuation of Nuwellis, Inc. (NUWE) demonstrates a support level, where the value 0.30 describes the current level. The sale of high-margin blood filtration consumables ensures stability, while robotic assembly of units minimizes the impact of human error on product quality.

NUWE Multiplikator P/S Nuwellis Inc (04.07.2022 - 15.11.2026)

Rincian analitis perusahaan nuwellis.com (NUWE)

- rega saham lan konsensus proyeksi valuasi:
Analisis umum perusahaan:NUWE Nuwellis Inc
Barang utama Nuwellis, Inc.

The P/S business valuation for Nuwellis, Inc. (NUWE) reflects the market value of each unit of revenue generated from ultrafiltration system sales within the context of management's drive toward operational profitability. This ratio compares total market capitalization to annual sales volume, allowing investors to determine the asset's degree of overvaluation and assess correction risks during shifts in economic cycles.

Pesaing Nuwellis, Inc.

DXCM (DexCom Inc) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S PEN (penumbrainc.com)|NOVT - Kapitalisasi marang pendapatan|Haemonetics - Multiplikator P/S|Rega marang dodolan Inspire Medical Systems|PRCT: Multiplikator P/S|Rasio kapitalisasi marang pendapatan CNMD|PLSE (Pulse Medical) - Multiplikator P/S|InMode Corp (INMD) - Koefisien rega marang pendapatan|Multiplikator P/S PMI|Kapitalisasi marang pendapatan Surmodics, Inc. SRDX|Multiplikator P/S SENS (senseonics.com)|Multiplikator P/S NeuroPace Inc NPCE|TCMD - Rasio rega marang pendapatan|SNWV: Rasio rega marang pendapatan|Outset Medical Corp (OM) - Rasio rega marang pendapatan|SmartVest - Rasio kapitalisasi pasar marang pendapatan|LNSR (LENSAR Inc) - Multiplikator P/S|Rega marang dodolan AVITA Medical Inc. RCEL|Rasio rega marang pendapatan Profound Medical (PROF)|Baird Medical Corp (BDMD) - Multiplikator rega marang pendapatan|EDAP TMS SA - Kapitalisasi marang pendapatan|Multiplikator P/S Bovie Medical APYX|IceCure Medical Ltd. - Multiplikator P/S|Koefisien rega marang pendapatan Pulmonx LUNG|TELA Bio (TELA) - Rasio rega marang pendapatan|Rasio rega marang dodolan CTSO (CytoSorbents Corp.)|Rasio rega marang pendapatan sensushealthcare.com|Kapitalisasi marang pendapatan Zynex, Inc. (ZYXI)|Multiplikator P/S ECOR|RBOT - Rega marang dodolan|Rasio rega marang pendapatan inspira-technologies.com IINN|Kapitalisasi marang volume dodolan ICU (SeaStar Medical Holding Corp.)|IRIX: Kapitalisasi marang pendapatan|ibs.inc - Kapitalisasi marang volume dodolan|XAIR: Multiplikator P/S|Rasio rega marang dodolan PFSA (Profusa Inc.)|Kapitalisasi marang pendapatan SSKN|Rasio rega marang pendapatan GCTK|Rasio rega marang pendapatan NanoVibronix (NAOV)|Venus Concept - Rasio kapitalisasi marang pendapatan|Multiplikator P/S AEMD (Aethlon Medical, Inc.)|ASXC: Rasio kapitalisasi marang pendapatan|Avinger Inc. - Multiplikator P/S|Koefisien rega marang pendapatan BioSig Technologies, Inc BSGM|CUTR: Multiplikator P/S|Know Labs, Inc. (KNW) - Multiplikator P/S|Rasio rega marang pendapatan Inari Medical Inc|Kapitalisasi marang pendapatan Nevro Corp (NVRO)|Kapitalisasi marang pendapatan RSLS (ReShape Lifesciences, Inc.)|Multiplikator P/S Silk Road Medical Inc. (SILK)